Denali Therapeutics (DNLI) Tax Provisions (2019 - 2023)
Denali Therapeutics' (DNLI) quarterly Tax Provisions came in at $30000.0 in Q4 2023, up 600.0% year-on-year from $4285.7 in Q4 2022, and up 600.0% on a QoQ basis from -$6000.0 in Q4 2022.
Denali Therapeutics (DNLI) Tax Provisions (2019 - 2023) Analysis & Trends
Denali Therapeutics (DNLI) has 5 years of Tax Provisions data on file, last reported at $30000.0 in Q4 2023.
- On a quarterly basis, Tax Provisions rose 600.0% year-over-year to $30000.0 in Q4 2023; TTM through Dec 2023 was $24000.0, a 104.33% increase from a year earlier, with the FY2025 full-year figure at $102000.0, up 50.0% from the prior year.
- Tax Provisions for Q4 2023 stood at $30000.0, up from -$6000.0 in the prior quarter.
- Over the last five years, Tax Provisions for DNLI reached as high as $823000.0 in Q4 2020 and fell as low as -$575000.0 in Q4 2021.
- Historically, Tax Provisions has averaged -$37900.0 across 5 years, with a median of $10500.0 in 2022.
- Across the five-year window, Tax Provisions slumped 169.87% in 2021 and surged 600.0% in 2023, its largest moves.
- Year by year, Tax Provisions stood at -$400000.0 in 2019, then jumped by 305.75% to $823000.0 in 2020, then slumped by 169.87% to -$575000.0 in 2021, then surged by 98.96% to -$6000.0 in 2022, then jumped by 600.0% to $30000.0 in 2023.
- Per Business Quant data, the three most recent Tax Provisions figures were $30000.0 in Q4 2023, -$6000.0 in Q4 2022, and $27000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Denali Therapeutics | 4.33 Bn | 4.33 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 30,000.00 |
| Dec 31, 2022 | -6,000.00 |
| Jun 30, 2022 | 27,000.00 |
| Dec 31, 2021 | -575,000.00 |
| Dec 31, 2020 | 823,000.00 |
| Sep 30, 2020 | 56,000.00 |
| Jun 30, 2020 | 79,000.00 |
| Mar 31, 2020 | -100,000.00 |
| Sep 30, 2019 | -400,000.00 |
| Jun 30, 2019 | -313,000.00 |